On Friday, Shares of CSX Corporation (NYSE:CSX), lost -0.23% to $35.47.
The Association of American Railroads (AAR) recognized CSX employee Suneil Kuthiala with the John H. Chafee Environmental Excellence Award for his outstanding environmental leadership, especially in the area of fuel efficiency.
Kuthiala is a director of advanced engineering at CSX, with 14 years of service with the company in positions across engineering and technology. Presently, Kuthiala oversees the implementation and development of a technology solution, GE’s Trip Optimizer, to improve fuel efficiency and reduce greenhouse gas (GHG) emissions.
CSX Corporation, together with its auxiliaries, provides rail-based transportation services in the United States and Canada. It offers traditional rail services, and transports intermodal containers and trailers.
Shares of Texas Instruments Incorporated (NASDAQ:TXN), declined -0.24% to $55.37, during its last trading session.
Texas Instruments Incorporated (TI) (TXN) Chairman, President and Chief Executive Officer Rich Templeton will speak at Sanford C. Bernstein’s 31st Annual Planned Decisions Conference 2015 in New York City on Wednesday, May 27, at 11 a.m. Eastern time. Templeton will field questions from analysts and investors, in addition to talk about TI’s business outlook and its strategy to address key markets for its analog and embedded processing technologies and how these capabilities position the company for growth.
Texas Instruments Incorporated designs, manufactures, and sells semiconductors to electronics designers and manufacturers worldwide. It operates through two segments, Analog and Embedded Processing.
At the end of Friday’s trade, Shares of Monsanto Company (NYSE:MON), gained 0.24% to $ 120.29.
Highlighting its innovation advantage in meeting the long-term demand to feed a growing population, Monsanto Company (MON) will cite the company’s unique ability to lead the next evolution in agriculture. Speaking to investors at the BMO Capital Markets 10th Annual Farm to Market Conference in New York, Monsanto’s President and Chief Operating Officer
Brett Begemann will talk about how Monsanto’s ability to innovate and share value with farmers continues to be its planned differentiator.
“The future of agriculture belongs to those who sustainably steward every field – with precise, integrated solutions to enhance the productivity of every seed on an increasingly static footprint,” Begemann will note. “Companies with a track record of innovation and with the vision and discipline to execute will succeed in this new space.”
Monsanto Company, together with its auxiliaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. The Seeds and Genomics segment produces row crop seeds, counting corn, soybean, cotton, and canola seeds principally under the DEKALB, Channel, Asgrow, and Deltapine brands; and vegetable seeds compriseing of tomato, pepper, melon, cucumber, pumpkin, squash, beans, broccoli, onions, lettuce, and other seeds under the Seminis and De Ruiter brands.
Finally, Nanosphere, Inc. (NASDAQ:NSPH), ended its last trade with -2.36% lost, and closed at $ 3.73.
Nanosphere, Inc. (NSPH), declared the closing of its formerly declared registered direct offering of $4,400,000 of Series A Convertible Preferred Stock (which are convertible into a total of 1,168,659 shares of common stock at a conversion price of $3.765) and warrants to purchase shares of common stock exercisable for up to 1,168,659 additional shares of common stock, in the aggregate. The warrants have an exercise price of $3.65 per share and are exercisable for 5 years commencing six months from the closing date. The preferred stock is perpetual and does not have a required dividend right or voting rights and has a liquidation preference of $0.01 per share. The preferred stock has a limitation on conversion into common stock to preclude the holder from acquiring beneficial ownership of more than 4.99% of our outstanding common stock, which may be raised to 9.99% in certain circumstances. As part of the fee payable to the placement agent in connection with the offering, Nanosphere also issued to the placement agent and certain of its principals warrants to purchase an aggregate of 70,120 shares of common at an exercise price of $4.45 per share. H.C. Wainwright & Co. acted as the exclusive placement agent in connection with this offering. Terms of the Series A Convertible Preferred Stock and the common stock warrants are described in the Company’s current report on Form 8-K filed with the SEC on May 14, 2015.
Nanosphere, Inc. develops, manufactures, and markets molecular diagnostic tests that can lead to earlier disease detection, optimal patient treatment, and improved healthcare economics. It offers a molecular diagnostics platform, Verigene System platform that enables clinicians to identify and treat the bacteria and viruses for complex, costly, and deadly infectious diseases.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
